{"id":55872,"date":"2026-01-30T12:29:27","date_gmt":"2026-01-30T04:29:27","guid":{"rendered":"https:\/\/flcube.com\/?p=55872"},"modified":"2026-01-30T12:29:28","modified_gmt":"2026-01-30T04:29:28","slug":"cspc-pharma-signs-18-5b-astrazeneca-deal-for-weight-management-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55872","title":{"rendered":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio"},"content":{"rendered":"\n<p><strong>CSPC Pharmaceutical Group Ltd<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/1093:HKG\">HKG:\u202f1093<\/a>) announced a landmark partnership with <strong>AstraZeneca Plc<\/strong> (AZ, <a href=\"https:\/\/www.google.com\/finance\/quote\/AZN:NASDAQ\">NASDAQ:\u202fAZN<\/a>) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-structure-amp-financial-terms\">Deal Structure &amp; Financial Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>CSPC Pharmaceutical (HKEX:\u202f01093) \/ AstraZeneca (Nasdaq:\u202fAZN)<\/td><\/tr><tr><td><strong>Technology Platforms<\/strong><\/td><td>Sustained\u2011release delivery + Peptide drug AI discovery<\/td><\/tr><tr><td><strong>Geographic Rights<\/strong><\/td><td>AstraZeneca: Global exclusive (excl. Mainland China, HK, Macau, Taiwan)<\/td><\/tr><tr><td><strong>Portfolio<\/strong><\/td><td>8 projects (1 Phase\u202fI\u2011ready, 3 preclinical, 4 co\u2011development)<\/td><\/tr><tr><td><strong>Upfront Payment<\/strong><\/td><td>USD\u202f1.2\u202fbillion<\/td><\/tr><tr><td><strong>Development Milestones<\/strong><\/td><td>Up to USD\u202f3.5\u202fbillion<\/td><\/tr><tr><td><strong>Sales Milestones<\/strong><\/td><td>Up to USD\u202f13.8\u202fbillion<\/td><\/tr><tr><td><strong>Royalties<\/strong><\/td><td>Tiered, up to double\u2011digit percentage<\/td><\/tr><tr><td><strong>Total Deal Value<\/strong><\/td><td>Up to USD\u202f18.5\u202fbillion<\/td><\/tr><tr><td><strong>Strategic Focus<\/strong><\/td><td>Once\u2011monthly injectable weight management\/obesity therapies<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-pipeline-overview\">Product Pipeline Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Project<\/th><th>Stage<\/th><th>Mechanism<\/th><th>Status<\/th><\/tr><\/thead><tbody><tr><td><strong>SYH2082<\/strong><\/td><td>Phase\u202fI\u2011ready<\/td><td>Long\u2011acting GLP1R\/GIPR agonist<\/td><td>Advancing to trials<\/td><\/tr><tr><td><strong>Project 2<\/strong><\/td><td>Preclinical<\/td><td>Distinct MOA<\/td><td>Part of portfolio<\/td><\/tr><tr><td><strong>Project 3<\/strong><\/td><td>Preclinical<\/td><td>Distinct MOA<\/td><td>Part of portfolio<\/td><\/tr><tr><td><strong>Project 4<\/strong><\/td><td>Preclinical<\/td><td>Distinct MOA<\/td><td>Part of portfolio<\/td><\/tr><tr><td><strong>Projects 5\u20118<\/strong><\/td><td>Co\u2011development<\/td><td>Various<\/td><td>Based on platforms<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-market-impact\">Strategic Rationale &amp; Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Obesity Market:<\/strong> Global obesity therapeutics market projected to reach <strong>$100\u202fbillion<\/strong> by 2030; long\u2011acting monthly injectables represent next\u2011generation convenience<\/li>\n\n\n\n<li><strong>Technology Edge:<\/strong> CSPC\u2019s sustained\u2011release platform enables monthly dosing versus current weekly injectables (Wegovy, Zepbound), improving patient adherence<\/li>\n\n\n\n<li><strong>AI Discovery:<\/strong> Peptide AI platform accelerates identification of novel dual\/triple agonists with enhanced efficacy and safety profiles<\/li>\n\n\n\n<li><strong>Validation:<\/strong> Deal validates CSPC\u2019s R&amp;D capabilities on global stage; positions company as leader in metabolic disease innovation<\/li>\n\n\n\n<li><strong>AstraZeneca Strategy:<\/strong> Bolsters AZ\u2019s obesity pipeline alongside Phase\u202fII GLP\u20111\/GIP program; addresses critical gap versus Novo Nordisk and Eli Lilly<\/li>\n\n\n\n<li><strong>China Retention:<\/strong> CSPC retains Greater China rights, allowing parallel domestic development and potential licensing to local partners<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-next-steps-amp-timeline\">Next Steps &amp; Timeline<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>SYH2082 Phase\u202fI:<\/strong> Initiation expected <strong>Q2\u202f2026<\/strong><\/li>\n\n\n\n<li><strong>Platform Expansion:<\/strong> 4 additional projects to be co\u2011developed over <strong>24\u2011month<\/strong> timeline<\/li>\n\n\n\n<li><strong>Milestone Triggers:<\/strong> Development milestones tied to Phase\u202fII\/III initiation and regulatory submissions; sales milestones linked to commercial launch across major markets<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding development timelines, milestone achievements, and revenue potential for the CSPC\u2011AstraZeneca collaboration. Actual results may differ due to clinical trial outcomes, competitive dynamics, and regulatory review processes.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026013000102_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026013000102_c.\"><\/object><a id=\"wp-block-file--media-ecea6b8d-d01d-40d7-9cdd-dadb171485fb\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026013000102_c.pdf\">2026013000102_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026013000102_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-ecea6b8d-d01d-40d7-9cdd-dadb171485fb\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":55875,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[130,770,171,855,4445,871,86],"class_list":["post-55872","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-astrazeneca","tag-az","tag-cspc-pharmaceutical","tag-hkg-1093","tag-metabolic-disease","tag-nasdaq-azn","tag-obesity"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55872\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio\" \/>\n<meta property=\"og:description\" content=\"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55872\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-30T04:29:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T04:29:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio\",\"datePublished\":\"2026-01-30T04:29:27+00:00\",\"dateModified\":\"2026-01-30T04:29:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872\"},\"wordCount\":382,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/3003.webp\",\"keywords\":[\"AstraZeneca\",\"AZ\",\"CSPC Pharmaceutical\",\"HKG: 1093\",\"Metabolic disease\",\"NASDAQ: AZN\",\"Obesity\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55872#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55872\",\"name\":\"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/3003.webp\",\"datePublished\":\"2026-01-30T04:29:27+00:00\",\"dateModified\":\"2026-01-30T04:29:28+00:00\",\"description\":\"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55872\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/3003.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/3003.webp\",\"width\":1080,\"height\":608,\"caption\":\"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55872#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55872","og_locale":"en_US","og_type":"article","og_title":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio","og_description":"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.","og_url":"https:\/\/flcube.com\/?p=55872","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-30T04:29:27+00:00","article_modified_time":"2026-01-30T04:29:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55872#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55872"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio","datePublished":"2026-01-30T04:29:27+00:00","dateModified":"2026-01-30T04:29:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55872"},"wordCount":382,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=55872#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","keywords":["AstraZeneca","AZ","CSPC Pharmaceutical","HKG: 1093","Metabolic disease","NASDAQ: AZN","Obesity"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55872#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55872","url":"https:\/\/flcube.com\/?p=55872","name":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=55872#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=55872#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","datePublished":"2026-01-30T04:29:27+00:00","dateModified":"2026-01-30T04:29:28+00:00","description":"CSPC Pharmaceutical Group Ltd (HKG:\u202f1093) announced a landmark partnership with AstraZeneca Plc (AZ, NASDAQ:\u202fAZN) to develop innovative long\u2011acting peptide drugs for weight management, leveraging its proprietary sustained\u2011release delivery and AI\u2011driven peptide discovery platforms.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55872#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55872"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=55872#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","width":1080,"height":608,"caption":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55872#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/3003.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55872"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55872\/revisions"}],"predecessor-version":[{"id":55876,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55872\/revisions\/55876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/55875"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}